Clinical Trial Update: Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II [Phase 2]

View source ↗

Summary

Phase II, single-arm clinical trial evaluating induction with Sintilimab and Nimotuzumab followed by Nimotuzumab-containing chemoradiation in locally advanced h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-SCCHN) | Phase 2 | Status: NOT_YET_RECRUITING